Prontosan® Wound Irrigation Solution

with KCI V.A.C. VeraFloTM

REPORTED CLINICAL OUTCOMES & BENEFITS 7

Physicians at MedStar Georgetown University Hospital, Center STUDY RESULTS NPWT: n=74
NPWTi: n=34
for Wound Healing examined the impact of V.A.C. VeraFlo™
20 min dwell time
Therapy with Prontosan® Wound I­rrigation ­Solution (using either
REDUCED OR VISITS
a 6 or 20 min. soak time and n­ egative pressure of 3.5 hours or
3.0
2 hours at -125 mmHg) versus V.A.C.® Therapy in 142 patients
Reduction of
with ­infected wounds that required hospitalization and serial ~1 / 2 Trip
surgical debridement. 2.6 p = 0.003

Trips to OR V.A.C.® Therapy V.A.C. VeraFlo™

Therapy

REDUCED LENGTH OF STAY

14.9

Reduction of
~ 4 days
p = 0.034
11.4
Days

V.A.C.® Therapy V.A.C. VeraFlo™

Therapy
In this study V.A.C. VeraFlo™ Therapy with ­Prontosan® instillation was
more cost ­effective than V.A.C.® Therapy. An economic model based
REDUCED TIME TO FINAL SURGICAL PROCEDURE
on MedStar Georgetown University study results and cost modeling 9.2
assumptions indicates potential ­savings as high as:
Reduction of

$8,613
savings per patient in the
$9,117
savings per patient in the
7.5
~ 2 days
p = 0.002
Days

6 min. dwell time groupA 20 min. dwell time groupB

7) Kim PJ, Attinger CE, Steinberg JS, et al. The Impact of Negative-Pressure Wound Therapy with
Instillation Compared with Standard Negative-Pressure Wound Therapy: A Retrospective,
V.A.C.® Therapy V.A.C. VeraFlo™
Historical, Cohort, Controlled Study. Plast. Reconstr. Surg.2014; 133: 709-716.
Therapy
V.A.C. VeraFlo™ is a Trademark of KCI™ an Acelity™ company

B. Braun Medical AG | Infection Control | Seesatz 17 | CH-6204 Sempach

Phone +41 58 258 50 00 | Fax +41 58 258 60 00 | info.bbmch@bbraun.com | www.bbraun.com

IC2717_11.2016